Details for Patent: 7,947,654

Summary for Patent: 7,947,654

Title:	Pharmaceutical formulations
Abstract:	Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
Inventor(s):	Nilsson; Anders (Lund, SE), Lindner; Hans (Leichlingen, DE), Wittendorff; Jorgen (Hvidovre, DK)
Assignee:	Ferring B.V. (Hoofddorp, NL)
Application Number:	12/487,116
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,947,654
Patent Claim Types: see list of patent claims	Composition; Formulation; Dosage form;

Drugs Protected by US Patent 7,947,654

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 7,947,654

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0210397.6	May 7, 2002
	PCT/IB02/04036	Sep 20, 2002

International Family Members for US Patent 7,947,654

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	039092
Argentina	039794
Argentina	107948
Austria	333886